Literature DB >> 23307242

Investigation on MDR1 gene polymorphisms and its relationship with breast cancer risk factors in Chinese women.

Yi Fang1, Qingyu Zhao, Gang Ma, Yujing Han, Ning Lou.   

Abstract

The human multidrug resistance 1 gene (MDR1) is an important candidate gene influencing the susceptibility to various diseases, including breast cancer. The object of this study was to investigate on MDR1 gene polymorphisms and its relationship with the susceptibility to breast cancer. A total of 271 patients with breast cancer and 225 healthy controls were enrolled in this study. Data about the risk factors for breast cancer were collected using questionnaires. Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and DNA sequencing methods were used to investigate the c.3073A > C polymorphisms. We observed no significant differences in the allelic and genotypic frequencies of c.3073A > C polymorphisms between patients and control subjects. Furthermore, there were no significant differences about the distribution of the breast cancer patients' risk factors among AA, AC and CC genotype. Results from this study suggested that c.3073A > C polymorphism was not associated with the susceptibility to breast cancer in the studied population. Future studies evaluating the association between c.3073A > C variant and breast cancer risks are essential to reach to more reliable results on larger populations.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23307242     DOI: 10.1007/s12032-012-0375-9

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  26 in total

1.  MDR1 C3435T polymorphism and cancer risk: a meta-analysis based on 39 case-control studies.

Authors:  Xiaojing Sheng; Limei Zhang; Na Tong; Dewei Luo; Meilin Wang; Min Xu; Zhengdong Zhang
Journal:  Mol Biol Rep       Date:  2012-02-04       Impact factor: 2.316

Review 2.  Common BRCA1 and BRCA2 mutations in breast cancer families: a meta-analysis from systematic review.

Authors:  Furu Wang; Qiaoqiao Fang; Zhen Ge; Ningle Yu; Sanxiao Xu; Xiangyong Fan
Journal:  Mol Biol Rep       Date:  2011-06-04       Impact factor: 2.316

3.  Multidrug resistance in breast cancer: a meta-analysis of MDR1/gp170 expression and its possible functional significance.

Authors:  B J Trock; F Leonessa; R Clarke
Journal:  J Natl Cancer Inst       Date:  1997-07-02       Impact factor: 13.506

4.  Genetic polymorphism of CYP17 and breast cancer risk in Korean women.

Authors:  Myung-Hee Shin; Kyoung-Mu Lee; Jung-Hyun Yang; Seok Jin Nam; Jong-Won Kim; Keun-Young Yoo; Sue Kyung Park; Dong-Young Noh; Sei-Hyun Ahn; Bongcheol Kim; Daehee Kang
Journal:  Exp Mol Med       Date:  2005-02-28       Impact factor: 8.718

Review 5.  Adjuvant therapy of primary breast cancer: a review of key findings from the 7th international conference, St. Gallen, February 2001.

Authors:  M S Aapro
Journal:  Oncologist       Date:  2001

6.  Polymorphism in the P-glycoprotein drug transporter MDR1 gene in colon cancer patients.

Authors:  Mateusz Kurzawski; Marek Droździk; Janina Suchy; Grzegorz Kurzawski; Monika Białecka; Wanda Górnik; Jan Lubiński
Journal:  Eur J Clin Pharmacol       Date:  2005-05-24       Impact factor: 2.953

7.  Adenosine triphosphate-binding cassette B1 (ABCB1) (multidrug resistance 1) G2677T/A gene polymorphism is associated with high risk of lung cancer.

Authors:  Guillermo Gervasini; Juan Antonio Carrillo; Montserrat Garcia; Carmen San Jose; Agustin Cabanillas; Julio Benitez
Journal:  Cancer       Date:  2006-12-15       Impact factor: 6.860

8.  Investigation of MRP-1 protein and MDR-1 P-glycoprotein expression in invasive breast cancer: a prognostic study.

Authors:  Annemarie Larkin; Lorraine O'Driscoll; Susan Kennedy; Rachel Purcell; Elizabeth Moran; John Crown; Michael Parkinson; Martin Clynes
Journal:  Int J Cancer       Date:  2004-11-01       Impact factor: 7.396

Review 9.  Breast cancer in Iran: an epidemiological review.

Authors:  Seyed Mohsen Mousavi; Ali Montazeri; Mohammad Ali Mohagheghi; Alireza Mousavi Jarrahi; Iraj Harirchi; Masomeh Najafi; Mandana Ebrahimi
Journal:  Breast J       Date:  2007 Jul-Aug       Impact factor: 2.431

10.  MDR1 C3435T polymorphism in patients with breast cancer.

Authors:  Sebahat Turgut; Arzu Yaren; Raziye Kursunluoglu; Günfer Turgut
Journal:  Arch Med Res       Date:  2007-04-26       Impact factor: 2.235

View more
  5 in total

1.  XRCC1 genetic polymorphism acts a potential biomarker for lung cancer.

Authors:  Dao-Qi Zhu; Qiong Zou; Chun-Hong Hu; Jia-Li Su; Guang-Hua Zhou; Ping Liu
Journal:  Tumour Biol       Date:  2015-01-08

2.  Association analysis between MDR1 genetic variant and breast cancer risk factors in Chinese Han population.

Authors:  Yi Hu; Jingliang Wang; Haitao Tao; Huan Wang; Xin Zhang; Yao Cheng; Ruixin Li
Journal:  Med Oncol       Date:  2013-08-08       Impact factor: 3.064

3.  The influence of genetic polymorphisms in MDR1 gene on breast cancer risk factors in Chinese.

Authors:  Yunhe Jia; Wenjing Tian; Shuai Sun; Peng Han; Weinan Xue; Mingqi Li; Yanlong Liu; Shixiong Jiang; Binbin Cui
Journal:  Med Oncol       Date:  2013-05-21       Impact factor: 3.064

4.  Investigation on XRCC1 genetic polymorphism and its relationship with breast cancer risk factors in Chinese women.

Authors:  Luming Zheng; Feng Yang; Xukui Zhang; Jian Zhu; Pen Zhou; Fang Yu; Lei Hou; Guowei Zhao; Qingqing He; Baocheng Wang
Journal:  Med Oncol       Date:  2013-10-25       Impact factor: 3.064

5.  Association between single genetic polymorphisms of MDR1 gene and gastric cancer susceptibility in Chinese.

Authors:  Wen Qiao; Tao Wang; Li Zhang; Qing Tang; Dan Wang; Hongkun Sun
Journal:  Med Oncol       Date:  2013-06-26       Impact factor: 3.064

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.